Trials / Completed
CompletedNCT02849977
Genetic Testing and Phenotypic Characterization of Severely Obese Pediatric and Adult Volunteers
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,966 (actual)
- Sponsor
- Rhythm Pharmaceuticals, Inc. · Industry
- Sex
- All
- Age
- 2 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this screening study is to identify people who have a rare genetic cause of obesity - specifically three genetic variants (a change in the DNA structure) of the POMC, PCSK1 and LepR genes that are currently known to result in obesity. This screening study will not include any investigational drugs. You will be asked to provide a DNA sample and answer some questions about your medical history and hunger.
Conditions
Timeline
- Start date
- 2016-09-28
- Primary completion
- 2020-06-09
- Completion
- 2020-06-09
- First posted
- 2016-07-29
- Last updated
- 2022-11-15
Locations
58 sites across 7 countries: United States, Canada, Germany, Greece, Israel, Italy, Portugal
Source: ClinicalTrials.gov record NCT02849977. Inclusion in this directory is not an endorsement.